InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-29 · accession 0001438133-21-000222 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-01 2021-11-29 TNDM Vosseller Leigh EVP, CFO F - Tax $129.66 -202 6,349 -3% -$26.2K
D 2021-12-01 2021-11-29 TNDM Vosseller Leigh EVP, CFO M - OptEx $0.00 +406 6,551 +7% $0
D 2021-12-01 2021-11-29 TNDM Vosseller Leigh EVP, CFO M - OptEx $0.00 +406 4,065 +11% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-29 F D 202 $129.66 6,349 D — —
2 Common Common Stock 2021-11-29 M A 406 $0.00 6,551 D — —
3 Derivative Restricted Stock Unit 2021-11-29 M A 406 $0.00 4,065 D — · — to — 406 Common Stock (F3) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F4) Each RSU represents a contingent right to receive one share of common stock of the Company. (F5) RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.